Components of the activated complement cascade are considered to play a pivotal role in ischemia reperfusion induced organ injury. Using intravital epifluorescence microscopy we investigated the effect of complement inhibition by the recombinant soluble complement receptor 1 (sCR1, TP10) on the effect of macromolecular microvascular permeability, functional capillary perfusion and leukocyte endothelium interaction in postischemic pancreatitis. Anaesthetised Sprague-Dawley rats were subjected to 60 min of normothermic pancreatic ischemia induced by microclipping of the blood supplying arteries of the organ. Rats who received intravenous sCR1 (15 mg/kg b.w.; n = 7) during reperfusion showed a significant reduction of permeability (1.77 ± 1.34 *10 -8 cm/s.; n = 7) of TRITC-Rhodamin labelled albumin injected 90 min after the onset of reperfusion as compared to vehicle treated animals (6.95 ± 1.56 *10 -8 cm/s) (n= 7). 120 min after the onset of reperfusion the length of red blood cell perfused capillaries (FCD) was significantly improved (from 279 ± 15.7 cm -1 to 330 ± 3.7 cm -1 .; n = 7) and the number of leukocytes adherent to postcapillary venules was significantly reduced (from 314 ± 87 mm -2 to 163 ± 71 mm -2 .; n = 7) by sCR1 as compared to vehicle treatment. Complement inhibition by sCR1 ameliorates effectively pancreatic ischemiareperfusion induced microcirculatory disturbances and might be considered for treatment of postischemic pancreatitis.
Introduction:
Ischemia-reperfusion is a causative factor in the pathogenesis of acute pancreatitis after mesenteric artery embolisation (20) , cardiac bypass operation (5) and the early inflammatory response after pancreas transplantation (21) . The stimulus of ischemiareperfusion induces generation of oxidative stress and following apoptosis of endothelial cells which are shown to activate the complement cascade by the classical (12) and Lectin (4) mediated pathway. Furthermore ischemia reperfusion in pancreas is considered to activate and release trypsin which is a well known activator of the complement cascade (5) . Microcirculatory pancreatic damage showing impairment of functional capillary perfusion (7), activation and adhesion of leukocytes in postcapillary venules (7) and increase of endothelial macromolecular permeability (3) are the crucial hallmarks of early reperfusion. Recombinant soluble complement receptor 1 (TP10, sCR1) has proven its therapeutic usefulness in ischemia-reperfusion injury of myocardium (31) , skeletal muscle (17) and small intestine (32) through blocking of the complement cascade during the early onset of reperfusion. Furthermore sCR1 ameliorated graft function after experimental kidney (18) , lung (15) and liver transplantation (10) . Due all these studies reduction of microcirculatory disturbances by inhibition of leukocyte adherence and preservation of the endothelial barrier function was considered as the decisive effect of sCR1 in reperfusion injury. Although graft pancreatitis is one of the major complications of pancreas transplantation up to now there is no reliable prevention of this early postischemic microcirculatory disturbance.
The aim of this study was to investigate the effect of sCR1 on the early microcirculatory deterioration during ischemia-reperfusion-induced pancreatitis using a novel method of measuring macromolecular permeability combined with analysed leukocyte adherence and functional capillary perfusion by means of intravital microscopic technique.
Materials and Methods:

Anaesthesia and Monitoring
The experimental protocol of this study was approved by the local ethical governmental committee and conforms the Guiding principles in the Care and Use of Animals as approved by the Council of the American Physiologic Society. Male Sprague-Dawley rats (Charles River, Sulzfeld, Germany) weighing 180-260g were anaesthetised with ether and pentobarbital (50mg/kg body weight intraperitoneally) after an overnight fast with free access to tap water. After tracheotomy, respiration was volume controlled and heart rate. Rectal temperature was kept between 36.5°C and 37.5°C by means of a heating pad (Fa. Effenberger, Pfaffing, Germany). Adequate anaesthesia was maintained by intravenous infusion of pentobarbital (12mg /kg body wt/hr) and N 2 O admixture (0.65-0.75) to the inspired air. Arterial blood gases, acid/base status and blood lactate concentration were measured intermittently by a blood gas analyser (Ciba Corning 860, Chiron diagnostics GmbH, Fernwald, Germany) and were adjusted to the following values for baseline conditions by means of ventilator adjustment and i. v. injection of Na-bicarbonate 8.4%: pO 2 =100-120 mmHg, pCO 2 =30-40 mmHg, ph=7.39+ 0.02 and base excess=0+2. During the experiment, arterial pO 2 was kept above 90 mmHg by adjustment of FiO 2 , pCO 2 was kept below 45 mmHg by alteration of the breathing frequency. Hematocrit in arterial blood was measured by a Coultercounter T540 (Coulter Electronics, Hialeah, Florida, USA).
Animal Model and Experimental Protocol
After transverse laparatomy complete ischemia of the pancreas was induced by clipping the four blood supplying arteries (left gastric artery, gastroduodenal artery, splenic artery and caudal pancreaticoduodenal artery) to the pancreas by means of microvascular clips (closing force 70g, Aesculap, Tuttlingen, Germany). The complete microsurgical technique was described previously (7) . Sham operated animals underwent the surgical procedure without induction of ischemia. After a stabilisation period of 15 min animals were randomly assigned to three groups: (a) sham operated group without ischemia (sham control, n=7); (b) 1h ischemia group receiving i. v. 3ml/kg body weight vehicle (ischemia control, n=7); (c) 1h ischemia group receiving i. v. 15 mg/kg body weight sCR1 (ischemia sCR1, n=7). SCR1 was further injected into three sham operated animals (15 mg/kg body weight); they showed no significant differences as compared to animals of the sham control group (data not shown). The dose (15 mg/kg body weight) of sCR1 used has proven its efficacy in other experiments in rats (10) . Arterial blood samples (1ml) were taken for assay of serum total hemolytic complement activity before induction of ischemia, at the end of the experiment and were immediately replaced by aliquots of saline. 15 min after administration of the solutions the pancreas and spleen were exteriorised on an adjustable microscope stage and covered by a thin transparent plastic membrane to prevent drying. To avoid cooling of the organs, the whole animal and the stage were covered by swabs between the microscopy measurements. Arterial pressure (MAP) was continuously determined and registered on a recorder (Siemens XT Kompensograph, Siemens, Munich, Germany). 
Intravital Microscopy and Quantification of Microvascular Parameters
Intravital fluorescence microscopy of the pancreas was performed using a modified Dynamic microhematocrit H Tm of the pancreatic capillary field was measured in a separate experiment by the method described by Sarelius and Duling using the following formula (22) : 
Assay of Serum Total Hemolytic C Activity (CH 100 )
Blood was withdrawn through the arterial catheter and centrifuged (3000 rpm, 4°, 10 min) to obtain serum. The samples were then stored at -70° C until assayed. For an assay 5 µl of serum were added to wells placed in agarose gel containing standardized sheep erythrocytes sensitized with hemolysin (kit RC001; The Binding Site, San Diego, CA). Plates were incubated for 18 h at 4° C and then for 1h at 37°C. The areas of the zones of hemolysis around each well (radial immunodiffusion) were measured by imaging these zones with a charge coupled device (CCD) camera, after scanning of the images. Their relative optical densities was calculated using software based evaluation for analysing electrophoretic gels. These values were converted to CH 100 units (one unit being the amount of C that lyses 100% of the erythrocytes) by interpolation from calibration curves plotted using the manufacturer`s standard, diluted from neat to 1: 32 ( minimum sensitivity, 32 CH 100 units).
Statistical Analysis
All data are presented as the mean values ± SD. Data analysis was performed using a statistical software package (Sigma Stat 2.0, Jandel Scientific Software, Jandel
Corporation, San Rafael, CA, U. S. A.). Data comparison between the groups were tested by Mann-Whitney U test followed by a Bonferroni-Holm correction. Within each group Friedman repeated-measures ANOVA on ranks followed by Dunett`s method was performed. P< 0.05 was considered to be statistically significant.
Results:
Macrohemodynamics and General Data
There was no significant difference of mean arterial pressure in sham operated animals during the whole observation time (Fig.1) . In both ischemia groups mean arterial pressure dropped significantly as compared to baseline values and sham operated animals at the early onset of reperfusion. In sCR1 treated group this drop of MAP could not be reversed completely and was more severe as compared to initial control values during the whole reperfusion time. While there were no significant changes in lactate values (Tab.: 1) in the sCR1 treated and sham operated animals, lactate values were significantly increased in the vehicle treated ischemia group 120min after reperfusion.
Hematocrit and negative base excess values were significantly higher 120 min after reperfusion in both ischemic groups as compared to sham animals.
Microvascular Permeability
90 mins after reperfusion vehicle treated animals showed a significant increase (6.95 ± 1.56 *10 -8 cm/s; n=7 p<0.01) of Rhodamin labelled albumin permeability as compared to the sham group (3.18 ± 0.7 *10 -8 cm/s; n = 7). SCR1 treatment resulted in significant (p<0.01) reduction of permeability (1.77 ± 1.34 *10 -8 cm/s.; n = 7) when compared with the vehicle treated group. There was no significant difference of microvascular permeability between sham and sCR1 treated animals undergoing ischemia.
Functional Capillary Density
Functional capillary density (Fig.: 3) was reduced to 279 ± 15.7 cm -1 (n=7, p<0.01) and 330 ± 3.7 cm -1 (n=7, p<0.01) in vehicle and sCR1 treated ischemia groups respectively when compared to sham animals (393 ± 8.9 cm -1 ; n = 7). The treatment with sCR1 was associated with impaired FCD (p<0.01) as compared to the vehicle treated group.
Leukocyte-Endothelium Interaction
Normothermic ischemia reperfusion of the pancreas resulted in a significant (163 ± 71 (29) we could show that activation of the complement system during the early onset of reperfusion is a crucial event of the initiation of the edema formation in postischemic pancreatitis.
In the current study we could observe an increase of the functional capillary perfusion during the reperfusion by sCR1 treatment. Although we found a significant difference between both ischemic groups as compared to the control group FCD is not significantly different at the end of the experiment when microcirculatory data are measured. Therefore to our opinion the existing tendencies of differences of the mean arterial pressure during reperfusion cannot explain the differences seen in functional capillary density and microvascular permeability after 90 and 120 mins. Capillary "noreflow" is a crucial hallmark of microcirculatory dearangement of the pancreatic ischemia reperfusion damage (7; 27) . Since erythrocyte perfused capillaries are very Total hemolytic complement activity was reduced after ischemia reperfuison of the pancreas in vehicle treated animals, which might be a sign of complement activation in the pathophysiologic setup of ischemia reperfusion induced pancreatitis. sCR1 treatment resulted in a reduction of microcirculatory reperfusion damage. Hemolytic complement activity was still reduced after sCR1 treatment as compared to baseline values which is similar to the data obtained after kidney transplantation and sCR1 treatment in rats (18) . Unfortunately the cited paper shows no data of complement activity in the transplantation group not receiving sCR1 making the interpretation and comparison of the significant reduction of hemolytic activity in the vehicle treated control group very difficult. The measured parameter might thus resemble on the one hand increased consumption of complement components by postischemic pancreatitis on the other hand a sustained blocking of the complement system by sCR1 which would be expected to be more pronounced during the first 30 mins after sCR1 injection.
In conclusion the data presented are the first proof that blocking the complement system by sCR1 in the early reperfusion period is an effective approach for preservation of microcirculatory disturbances such as increased macromolecular permeability, capillary perfusion failure and leukocyte adherence. Thus sCR1 might become a therapeutic option for prevention of reperfusion injury in the clinical setting of pancreas transplantation. [cm 
